Medicare Enrolled
Dr. Stuart Fox, M.D.
Neurology · Morristown, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Fox from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Fox?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Fox
Dr. Stuart Fox is a neurology specialist in Morristown, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Fox performed 1,150 Medicare services across 914 unique beneficiaries.
Between the years covered by Open Payments, Dr. Fox received a total of $82,980 from 99 pharmaceutical and/or device companies across 1097 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Fox is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 32% volume in NJ
$82,980 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,150
Medicare services
Top 32% in NJ for neurology
914
Unique beneficiaries
$115
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~58 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
510 | $98 | $144 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
133 | $135 | $186 |
| New patient office visit, complex (60-74 min) | 99 | $180 | $260 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
76 | $74 | $101 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
64 | $146 | $195 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
53 | $180 | $237 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
52 | $81 | $113 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
45 | $146 | $203 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
24 | $68 | $86 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
22 | $97 | $139 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
21 | $48 | $91 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
20 | $111 | $142 |
| Nerve conduction studies, 5-6 tests A series of 5 to 6 tests that measure how well nerves send electrical signals. The procedure evaluates nerve function and helps identify damage or dysfunction. |
17 | $117 | $161 |
| Nerve conduction studies, 7-8 tests A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles. |
14 | $151 | $200 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$82,980
Total received (2018-2024)
Avg $11,854/year across 7 years
Top 5% in NJ for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
99
Companies
1,097
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$65,290 (78.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,691 (15.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$4,999 (6.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,975
2023
$2,375
2022
$2,382
2021
$8,417
2020
$9,458
2019
$23,285
2018
$35,087
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$414
Novartis Pharmaceuticals Corporation
$169
Teva Pharmaceuticals USA, Inc.
$166
PFIZER INC.
$162
Celgene Corporation
$141
ARGENX US, INC.
$102
CSL Behring
$98
Biogen, Inc.
$85
Eisai Inc.
$83
Lundbeck LLC
$71
SK Life Science, Inc.
$67
TG Therapeutics, Inc.
$59
Alexion Pharmaceuticals, Inc.
$55
EMD Serono, Inc.
$51
Lilly USA, LLC
$49
Neurocrine Biosciences, Inc.
$48
Avadel CNS Pharmaceuticals, LLC
$33
GE HEALTHCARE
$29
Genentech USA, Inc.
$18
UCB, Inc.
$17
AstraZeneca Pharmaceuticals LP
$17
Amneal Pharmaceuticals LLC
$15
Azurity Pharmaceuticals, Inc.
$14
Aucta Pharmaceuticals, Inc.
$13
Top 3 companies account for 37.9% of 2024 payments
All-time payments by company (2018-2024) ›
Teva Pharmaceuticals USA, Inc.
$32,834
Genentech USA, Inc.
$25,567
GENZYME CORPORATION
$12,080
ABBVIE INC.
$1,246
Novartis Pharmaceuticals Corporation
$1,173
Biogen, Inc.
$806
UCB, Inc.
$480
Alexion Pharmaceuticals, Inc.
$452
Supernus Pharmaceuticals, Inc.
$441
Allergan, Inc.
$430
Celgene Corporation
$409
CSL Behring
$380
Sunovion Pharmaceuticals Inc.
$371
EMD Serono, Inc.
$369
PFIZER INC.
$351
Amgen Inc.
$280
Lundbeck LLC
$270
Allergan Inc.
$231
Lilly USA, LLC
$219
SK Life Science, Inc.
$210
Eisai Inc.
$192
Acorda Therapeutics, Inc
$186
Neurocrine Biosciences, Inc.
$181
GE HEALTHCARE
$153
Validus Pharmaceuticals LLC
$144
Biohaven Pharmaceutical Holding Company Ltd.
$141
ARGENX US, INC.
$129
AbbVie Inc.
$126
JAZZ PHARMACEUTICALS INC.
$123
Abbott Laboratories
$117
Grifols USA, LLC
$115
Amneal Pharmaceuticals LLC
$114
Janssen Pharmaceuticals, Inc
$113
ACADIA Pharmaceuticals Inc
$111
UPSHER-SMITH LABORATORIES LLC
$108
W. L. Gore & Associates, Inc.
$107
Biohaven Pharmaceuticals, Inc.
$97
Bausch Health US, LLC
$90
Nevro Corp.
$88
Adamas Pharmaceuticals, Inc.
$84
Greenwich Biosciences, Inc.
$83
TG THERAPEUTICS, INC.
$78
Avion Pharmaceuticals
$62
Boston Scientific Corporation
$61
Takeda Pharmaceuticals U.S.A., Inc.
$61
AstraZeneca Pharmaceuticals LP
$60
Neurelis, Inc.
$59
TG Therapeutics, Inc.
$59
Avanir Pharmaceuticals, Inc.
$58
Medtronic USA, Inc.
$58
ARBOR PHARMACEUTICALS, INC.
$58
Jazz Pharmaceuticals Inc.
$57
Vanda Pharmaceuticals Inc.
$57
Alnylam Pharmaceuticals Inc.
$56
EISAI INC.
$56
BOSTON SCIENTIFIC CORPORATION
$48
Mitsubishi Tanabe Pharma America, Inc.
$45
Mallinckrodt Enterprises LLC
$45
CATALYST PHARMACEUTICALS, INC.
$40
Exeltis, USA Inc.
$34
Avadel CNS Pharmaceuticals, LLC
$33
IMPEL PHARMACEUTICALS INC.
$31
Scilex Pharmaceuticals Inc.
$30
Currax Pharmaceuticals LLC
$29
ASSERTIO THERAPEUTICS, Inc.
$28
Kyowa Kirin, Inc.
$28
BANNER LIFE SCIENCES, LLC
$28
Impax Laboratories, Inc.
$28
ANI Pharmaceuticals, Inc.
$27
GE HealthCare
$27
Mallinckrodt LLC
$26
Assertio Therapeutics, Inc.
$26
Mallinckrodt Hospital Products Inc.
$20
Merz North America, Inc.
$18
E.R. Squibb & Sons, L.L.C.
$16
Sumitomo Pharma America, Inc.
$16
Piramal Imaging Limited
$16
Octapharma USA, Inc.
$15
Virtus Pharmaceuticals LLC
$15
Mylan Specialty L.P.
$15
Bayer HealthCare Pharmaceuticals Inc.
$15
SCILEX PHARMACEUTICALS INC.
$15
Adlon Therapeutics L.P.
$14
Aprecia Pharmaceuticals, LLC
$14
Azurity Pharmaceuticals, Inc.
$14
Collegium Pharmaceutical, Inc.
$14
Almatica Pharma LLC
$14
Axsome Therapeutics, Inc.
$14
MITSUBISHI TANABE PHARMA AMERICA, INC.
$14
Xeris Pharmaceuticals, Inc.
$14
Aucta Pharmaceuticals, Inc.
$13
Banner Life Sciences, LLC
$13
Alfasigma USA, Inc.
$13
Vertical Pharmaceuticals, LLC
$13
Sobi, Inc
$12
Akcea Therapeutics, Inc.
$12
Life Molecular Imaging Ltd
$12
AQUESTIVE THERAPEUTICS, INC.
$12
Harmony Biosciences LLC
$12
Top 3 companies account for 84.9% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ACTIVA · ADHANSIA XR · ADUHELM · AFINITOR · AIMOVIG · AJOVY · AMPYRA · AMYVID · ANDEXXA · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Aimovig · Austedo XR · BAFIERTAM · BOTOX · BOTOX THERAPEUTIC · BRILINTA · BRIUMVI · Betaseron · Briviact · CAMBIA · CARDIOFORM Septal Occluder · COMIRNATY · COPAXONE · CREXONT · Cambia · Corlanor · DIVIGEL · DUOPA · Dhivy · ELIQUIS · ELYXYB - celecoxib · EMGALITY · Enspryng · Epidiolex · Equetro · FANAPT · FIRDAPSE · Fycompa · GAMMAGARD · GENERAL - DBS · GILENYA · GOCOVRI · GORE CARDIOFORM Septal Occluder · GRALISE · Gamunex-C · General - DBS · Glatiramer Acetate · Gralise · HETLIOZ · HORIZANT · Hizentra · Horizant · INBRIJA · INFINITY · INGREZZA · KESIMPTA · KEVEYIS · KISUNLA · KYNMOBI · LEMTRADA · LEQEMBI · LEVORPHANOL TARTRATE · LUMRYZ · LYRICA · Leqembi · MAVENCLAD · MAYZENT · MIGRANAL · Mavenclad · Motpoly XR · NAMZARIC · NEURACEQ · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · Neuromodulation Dspsbls and Accs · Nourianz · OCREVUS · ONGENTYS · ONPATTRO · ONZETRA XSAIL · OXTELLAR XR · Ocrevus · Omnia · Ongentys · PANZYGA · PAXLOVID · PLEGRIDY · PURIFIED CORTROPHIN GEL · Ponvory · QULIPTA · RADICAVA · REXULTI · RYTARY · Radicava · Repatha · SOLIRIS · SPINRAZA · SUNOSI · SYMPAZAN · Senza · Soliris · Spritam · Sunosi · TECFIDERA · TEGSEDI · TOSYMRA · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · VALTOCO · VIIBRYD · VRAYLAR · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · Wakix · XEOMIN · XYREM · XYWAV · Xyrem · ZEPOSIA · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (79%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 5% for neurology in NJ.
Geographic Context
Neurologists within 10 mi
294
Per 100K population
57.6
County median income
$134,929
Nearest hospital
GREYSTONE PARK PSYCHIATRIC HOSPITAL
4.7 mi
4.7 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Fox is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 5% of NJ peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Fox experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Fox performed 510 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Fox receive payments from pharmaceutical companies?
Yes. Dr. Fox received a total of $82,980 from 99 companies across 1,097 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Fox's costs compare to other neurologists in Morristown?
Dr. Fox's average Medicare payment per service is $115. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Fox) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Morristown
Browse neurologists in Morristown ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in NJ
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in NJ
Which NJ neurologists receive the most from drug and device companies.
By company
Teva Pharmaceuticals USA, Inc. Payments to Doctors
See all physicians who received payments from Teva Pharmaceuticals USA, Inc.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc.
By company
GENZYME CORPORATION Payments to Doctors
See all physicians who received payments from GENZYME CORPORATION.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology